| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,583,224 | 4,171,725 | 3,565,072 | | Cost of Revenue | 3,607,312 | 3,325,410 | 2,878,711 | | | Gross Profit | 975,912 | 846,315 | 686,361 | | | Operating Expenses | | Research Development | 81,529 | 68,333 | 61,533 | | Selling General and Administrative | 401,426 | 347,454 | 285,100 | | Non Recurring | 108,500 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 384,457 | 430,528 | 339,728 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 905 | 1,431 | 1,212 | | Earnings Before Interest And Taxes | 385,362 | 431,959 | 340,940 | | Interest Expense | 63,392 | 81,578 | 76,144 | | Income Before Tax | 321,970 | 350,381 | 264,796 | | Income Tax Expense | 166,664 | 127,658 | 80,217 | | Minority Interest | (187) | (376) | (451) | | | | Net Income From Continuing Ops | 155,119 | 222,347 | 184,128 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 155,119 | 222,347 | 184,128 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $155,119 | $222,347 | $184,128 |
|
0.36% Nasdaq 
Income Statement
